The dengue vaccine industry is on a promising growth trajectory, with an estimated valuation of US$ 474.8 million in 2023. Anticipated demand for dengue vaccines is set to surge, with a projected sales volume CAGR of 12.9%. Dengue vaccine development has reached a pivotal phase in its lifecycle, marked by several pharmaceutical industry leaders poised to unveil …